Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 3 2Phase 1 1

Status

Recruiting 2Active not recruiting 2Not yet recruiting 1Completed 1

Sponsor Class

OTHER 3INDUSTRY 3

Study Type

Interventional 5Observational 1

Sponsor

Cancer Type

Myeloid 6Other hematologic neoplasm 1

Conditions

Myelodysplastic Syndromes 355Leukemia, Myeloid, Acute 297Myeloproliferative Disorders 155Leukemia, Myelogenous, Chronic, BCR-ABL Positive 139Precursor Cell Lymphoblastic Leukemia-Lymphoma 115Primary Myelofibrosis 101Leukemia, Myelomonocytic, Chronic 88Lymphoma, Non-Hodgkin 76Leukemia 69Polycythemia Vera 61Multiple Myeloma 55Hodgkin Disease 50Hematologic Neoplasms 48Leukemia, Lymphocytic, Chronic, B-Cell 43Lymphoma 40Leukemia, Biphenotypic, Acute 40Thrombocythemia, Essential 39Myelodysplastic-Myeloproliferative Diseases 31Neoplasms 29Leukemia, Myeloid, Chronic-Phase 28Anemia, Refractory, with Excess of Blasts 24Recurrence 22Anemia, Aplastic 21Lymphoma, Mantle-Cell 20Lymphoma, Follicular 20Hematologic Diseases 20Burkitt Lymphoma 20Blastic Plasmacytoid Dendritic Cell Neoplasm 20Blast Crisis 20Histiocytosis, Langerhans-Cell 18

Interventions

imetelstat 1Spectroscopy, Near-Infrared 1GRN163L peptide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Polycythemia × Myeloid × 1 year × Clear all
NCT07527221 2026-06-01

Safety and Tolerability of ZE74-0282 in Healthy Volunteers

Eilean Therapeutics

Phase 1 Recruiting
40 enrolled
MyeloidOther hematologic neoplasm

Polycythemia, Thrombocythemia, Essential, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Primary Myelofibrosis

NCT07341048 2026-01-15

ACTIVAQ

Hospices Civils de Lyon

Phase NA Not yet recruiting
54 enrolled
Myeloid

Polycythemia, Polycythemia Vera

NCT04576156 2025-12-04

A Study Comparing Imetelstat Versus Best Available Therapy for the Treatment of Intermediate-2 or High-risk Myelofibrosis (MF) Who Have Not Responded to Janus Kinase (JAK)-Inhibitor Treatment

Geron Corporation

Phase 3 Active not recruiting
327 enrolled
Myeloid

Myeloproliferative Disorders, Polycythemia, Thrombocytosis, Primary Myelofibrosis

NCT06421025 2025-11-21

POLYVISCO

Hospices Civils de Lyon

Recruiting
160 enrolled
Myeloid

Polycythemia, Polycythemia Vera, Thrombosis

NCT03008642 2025-09-19

Poly-CO

Centre Hospitalier Universitaire, Amiens

Phase NA Completed
60 enrolled
Myeloid

Myeloproliferative Disorders, Polycythemia

NCT05481151 2025-08-13

A Study to Assess Efficacy, Safety, and Tolerability of P1101 in Adult Patients With PV

PharmaEssentia

Phase 3 Active not recruiting
111 enrolled
Myeloid

Polycythemia, Polycythemia Vera, Thrombocythemia, Essential

Data powered by HemOnc (CC BY 4.0) Colophon âš¡